Design of GFB-111, a platelet-derived growth factor binding molecule with antiangiogenic and anticancer activity against human tumors in mice

@article{Blaskovich2000DesignOG,
  title={Design of GFB-111, a platelet-derived growth factor binding molecule with antiangiogenic and anticancer activity against human tumors in mice},
  author={Michelle A. Blaskovich and Qing Lin and Frederic L. Delarue and Jiazhi Sun and Hyung Soon Park and Domenico Coppola and Andrew D. Hamilton and Sa{\"i}d M. Sebti},
  journal={Nature Biotechnology},
  year={2000},
  volume={18},
  pages={1065-1070}
}
We have designed a molecule, GFB-111, that binds to platelet-derived growth factor (PDGF), prevents it from binding to its receptor tyrosine kinase, and blocks PDGF-induced receptor autophosphorylation, activation of Erk1 and Erk2 kinases, and DNA synthesis. GFB-111 is highly potent (IC50 = 250 nM) and selective for PDGF over EGF, IGF-1, aFGF, bFGF, and HRGβ (IC50 values > 100 μM), but inhibits VEGF-induced Flk-1 tyrosine phosphorylation and Erk1/Erk2 activation with an IC50 of 10 μM. GFB-111… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 21 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 31 references

Structural interactions of fibroblast growth factor receptor with its ligands.

Proceedings of the National Academy of Sciences of the United States of America • 2000

Protein surface recognition by synthetic receptors : a route to novel sub - micromolar inhibitors for chymotrypsin

Y. Hamuro, M. C. Calama, H. S. Park, A. D. Hamilton
J . Am . Chem . Soc . • 1999

A calixarene with four peptide loops : an antibody mimic for recognition of protein surfaces

C. Oefner, A. D. Arey, F. K. Winkler, B. Eggimann, M. Hosang
Angew . Chem . Int . Edn . Engl . • 1997

Similar Papers

Loading similar papers…